throbber
SPINE Volum< 26, Number 14, pp 1631-163S
`©2001, Lippincott Williams & Wilkins, Inc.
`
`•
`
`Initial Outcome and Efficacy of "Kyphoplasty" in the
`Treatment of Painful Osteoporotic Vertebral
`Compression Fractures
`
`I.H. Lieberman, MD, S. Dudeney, MD, M.-K. Reinhardt, RN, and G. Bell, MD
`
`Institutional Review Board-ap(cid:173)
`Study Design. An
`proved Phase I efficacy study of inflatable bone tamp
`usage in the treatment of symptomatic osteoporotic com(cid:173)
`pression fractures.
`Objectives. To evaluate the safety and efficacy of in(cid:173)
`flatable bone tamp reduction end cement augmentation,
`ukyphoplasty," in the treatment of painful osteoporotic
`vertebral compression fractures.
`Summary of Background Date. Osteoporotic compres(cid:173)
`sion fractures can result in progressive kyphosis and
`chronic pain. Traditional treatment for these patients in(cid:173)
`cludes bed rest, analgesics, and bracing. Augmentation of
`vertebral compression fractures with polymethylmethac(cid:173)
`rylate, "vertebroplasty," has been used to treat pain. This
`technique, however, makes no attempt to restore the
`height of the collapsed vertebral body. Kyphoplasty is a
`new technique that involves the introduction of inflatable
`bone tamps into the vertebral body. Once inflated, the
`bone tamps restore the vertebral body back toward its
`original height while creating a cavity that can be filled
`with bone cement.
`Patients and Methods. Seventy consecutive kypho(cid:173)
`plasty procedures were performed in 30 patients. The
`indications included painful primary or secondary osteo(cid:173)
`porotic vertebral compression fractures. Mean duration
`of symptoms was 5.9 months. Symptomatic levels were
`identified by correlating the clinical data with MRI find(cid:173)
`ings. Perioperative variables and bone tamp complica(cid:173)
`tions or issues were recorded and analyled. Preoperative
`and postoperative radiographs were compared to calcu(cid:173)
`late the perce-ntage height restored. Outcome data were
`obtained by comparing preoperative and latest postoper(cid:173)
`ative SF-36 data.
`Results. At the completion of the Phase I study there
`were no major complications related directly to use of this
`technique or use of the inflatable bone tamp. In 70% of
`the vertebral bodies kyphoplasty restored 47% of the lost
`height. Cement leakage occurred at six levels (8.6%).
`SF-36 scores for Bodily Pain 11.6-58.7, (P = 0.0001) and
`Physical Function 11.7-47.4, (P = 0.002) were among
`those that showed significant improvement.
`Conclusions. The inflatable bone tamp was efficacious
`in the treatment of osteoporotic vertebral compression
`fractures. Kyphoplasty is associated with early clinical
`improvement of pain and function as well as restoration
`of vertebral body height in the treatment of painful osteo(cid:173)
`porotic compression fractures. [Key words: kyphoplasty,
`vertebral compression fracture, osteoporosis, PMMA
`bone cement, vertebroplasty] Spine 2001;26:1631-1638
`
`From the Department of Orthopaedics, Cleveland Clinic Foundation,
`Cleveland, Ohio.
`Acknowledgment date: June 7, 2000.
`Acceptance date: November 6, 2000.
`Device status category: 3.
`Conflict of interest category: 12.
`
`Osteoporosis is a systemic disease affecting more than 24
`million Americans. It results in progressive bone mineral
`loss and concurrent changes in bony architecture, which
`leave the spinal column vulnerable to compression frac(cid:173)
`tures, often after minimal or no trauma. 17 There arc an
`estimated 700,000 osteoporotic vertebral compression
`fractures (VCFs) in the United States each year, of which
`more than one third become chronically painfuJ.S Ap(cid:173)
`proximately 85% of these fractures are due to primary
`osteoporosis5 and the remainder due to secondary osteo(cid:173)
`porosis or malignancies. These VCFs lead to progressive
`sagittal spine deformity and changes in spinal biome(cid:173)
`chanics and are believed to contribute to a fivefold in(cid:173)
`creased risk of further fracture by virtue of force trans(cid:173)
`mission to weak vertebrae above or below. 10 Whether
`the fracture is painful or not, the spinal deformity caused
`by two or more fractures dramatically impacts health,
`daily living, and medical costs through loss of lung ca(cid:173)
`pacity, loss of appetite, reduced mobility, chronic pain,
`18 The adverse effect on
`14
`and/or clinical depression. 3
`•
`•
`activities of daily living is almost as great as that seen
`with hip fractures. 9 The cost of managing osteoporotic
`VCF patients in the United States in 1995 was $746
`million.16 Osteoporotic VCFs have been shown to be
`associated with up to <1 30% ar~c-adjusred increase in
`mortality12 not observed with osteopo rotic distal radius
`fracture. 4 It has been shown thar there is a 9% loss in
`predicted forced vital capacity with each vertebral frac(cid:173)
`ture, 13 suggesting that the restrictive changes in thoracic
`anatomy are particularly harmful to patients with pre(cid:173)
`existing lung disease. These patients frequently complain
`of the true loss of height because of the fractures and the
`apparent loss of height because of the compensatory hip
`and knee flexion posturing secondary to the progressive
`thoracic and lumbar kyphosis. In summary, osteoporotic
`VCFs pose a significant clinical problem including pain,
`spinal deformity, reduced pulmonary function and mo(cid:173)
`bility, and an overall increase in mortality in this vulner-
`able group of patients.
`'
`Traditional treatment for patients with osteoporotic
`VCFs includes bed rest, analgesics, and bracing. This
`type of medical management obviously does nothing to
`restore spinal alignment, and the lack of mobility itself
`can increase the rate of demineralization. 10 Because of
`the inherent risks and invasive nature, surgical treatment
`of osteoporotic VCFs has been limited to cases in which
`there is concurrent spinal instability or neurologic com(cid:173)
`promise. Reconstruction with structural bone graft and
`instrumentation may be performed from an anterior or
`
`1631
`
`•
`
`STRYKER EXHIBIT 1030, pg. 1
`
`STRYKER CORPORATION v. ORTHOPHOENIX, LLC
`
`IPR2014-01519
`
`

`
`Figure 1. Inflatable bone
`tamp.
`
`posterior approach; however, the success of these tech(cid:173)
`niques is limited by the patient's poor bone quality and
`general medical condition.
`Augmentation of VCFs with polymethylmethacrylate
`(PMMA), "vertebroplasty" was first de.scribed by Gali(cid:173)
`bert ct al in 1987 for use in vertebral body tumors. 8 It
`involves the forced injection of low viscosity PMMA ce(cid:173)
`ment into the closed space of the collapsed vertebral
`body. Intra vertebral pressure is therefore required to en(cid:173)
`able low viscosity cement to infiltrate the compressed
`vertebral body. Although vertebroplasty is currently be(cid:173)
`ing used successfully for pain relief in VCFs,1
`15 this
`6
`7
`•
`•
`•
`technique makes no attempt to restore the height of the
`collapsed vertebral body. The principal limitation of ver(cid:173)
`tebroplasty is cement extravasation, the rates of which
`are as high as 65% in metastases19 and 30% when used
`to treat osteoporotic fractures. 11
`"Kyphoplasty" is a new technique with a number of
`potential advantages. This technique was conceived and
`developed by Dr. Mark Reiley (Berkley, CA). It involves
`the introduction of a cannula into the vertebral body,
`followed by insertion of an inflatable bone tamp (IBT)
`designed to reduce the vertebral body back toward its
`original height, while creating a cavity to be filled with
`bone cement. The cement augmentation is therefore
`done with more control into the low-pressure environ(cid:173)
`ment of the preformed cavity with viscous partially cured
`cement in an attempt to reduce the risk of extravasation.
`In this Phase I study we a imed to eva luate the efficacy
`of using IBT reduccion and ccmem augmentation, ky(cid:173)
`phoplasty, in the treatment of painful osteoporotic ver(cid:173)
`tebral compression fractures. Our emphasis is on ease of
`application, positioning, and safety, of the IBT, and ex(cid:173)
`tent of fracture reduction. We also aimed to examine the
`rate of cement extravasation and early patient outcomes.
`
`• Methods
`This study was designed as a single cohort study using consec(cid:173)
`utive prospectively gathered data examining early outcome and
`radiographic vertebral height restoration in no less than 20
`patients after kyphoplasty for osteoporotic compression frac-
`
`tures. The end point of this Institutional Review Board(cid:173)
`approved study was 3 months.
`
`Patients Seventy consecutive kyphoplasty procedures were
`performed in 30 patients over 38 sessions from April1999 ro
`March 2000. The mean age was 68.6 years (range 48-86
`years). The indications included painful primary (n = 19) or
`secondary (n = 5) osteoporotic vertebral compression fractures
`for a total of 24 patients unresponsive to nonoperative meth(cid:173)
`ods. A further six patients presented with painful compression
`fractures from multiple myeloma. The mean duration of symp(cid:173)
`toms was 5.9 months (0.5-24 months). Symptomatic levels
`were identified by correlating the clinical data with MRI find(cid:173)
`ings of marrow signal changes consistent with compression
`fractures. MRI was also used to confirm the presence of a true
`wedge compression fracture and rule out burst-type injuries
`with retropulsed bone.
`
`Kypboplasty Technique IBT placement involves identifying
`an extrapedicular or transpedicular entry point into the verte(cid:173)
`bral body using a guide pin, with the use of biplanar fluoros(cid:173)
`copy (Figures 1 and 2). This is followed by placement of a
`cannulated obturator over the guide wire. The obturator is then
`tapped into the bone over the guide wire. A working cannula is
`placed over the obturator and advanced until the tip of the
`cannula is seated in the posterior portion of the vertebral body.
`A hand-mounted drill bit is then used to ream a corridor for the
`IBT to be passed through. The IBTs are ideally situated under
`the collapsed endplate on the lateral radiograph. Inflation is
`slowly performed under fluoroscopy as are all stages of guide
`wire, obturator, and cannula placement. The inflation pressure
`of the lRT is monitored closely during inflation via an in-line
`pressure gauge. Inflation is continued up to a maximum pres(cid:173)
`sure of 220 psi or the maximum size dependent balloon volume
`is reached. Inflation should also be stopped if the balloon abuts
`any one of the cortical margins. When a suitable cavity has
`been prepared and as much reduction is achieved as is possible,
`the PMMA cement augmented with barium is mixed. Smaller
`cement cannulas, which fit inside the working cannula, arc
`filled with cement. Before its application the cement is allowed
`to thicken. A 2-cm 3 bolus of cement is repeatedly suspended
`from a wooden spatula, and when the viscosity is such that the
`cement does not fall from the spatula, it is ready for injection.
`The cement cannula is advanced through the working cannula
`
`STRYKER EXHIBIT 1030, pg. 2
`
`

`
`Kyphoplasty and Vertebral Compression Fractures • Lieberman et al 1633
`
`cannulation
`
`channel creation
`
`balloon tamp inflation
`
`resultant cavity
`
`cement application
`
`final cement fill
`
`Figure 2. Kyphoplasty steps, lateral fluoroscopic Images.
`
`to the anterior vertebral body wall, and cement is slowly ex(cid:173)
`truded using a stainless steel stylet, which acts as a plunger.
`Filling is performed under continuous lateral fluoroscopic
`guidance. The use of the stylet and bone filler cannula enables
`cement to be applied at considerably higher viscosity than pos(cid:173)
`sible with injection through a 5-mL syringe and 11-gauge nee(cid:173)
`dle. Cement filling is stopped when the cement mantle reaches
`two thirds of the way back to the posterior vertebral body
`cortex on the lateral fluoroscopic images. The number of ce(cid:173)
`ment cannulas that need to be prepared is estimated from the
`final inflation volume achieved with the IBTs. Often the volume
`applied is 1-2 mL greater than the final inflation volume allow(cid:173)
`ing cement from the central bolus to interdigitate with the sur(cid:173)
`rounding cancellous bone.
`
`Measurement of Height Restored: Radiographic Assess(cid:173)
`ment The vertical height of all fractured vertebrae were mea(cid:173)
`sured both before and after surgery (Figure 3). Vertebral height
`was defined as the distance (endplate to end plate) at the center
`of the vertebral body on the lateral radiograph. The vertical
`height of the vertebra above the fractured vertebra was also
`measured to give an estimate of the prefracture height. Calcu(cid:173)
`lations were made as follows: height regained = (post"
`treatment height - pretreatment fractured height), height lost
`= (estimated prcfracture height - prctreatmenr fractured
`height), percentage of height lost that is now restored = (height
`regained/height lost) X 100. The abso.lute values in height
`(mm) pretreatment and posNreatment were statistically com(cid:173)
`pared using paired nonparametric analysis (Wilcoxon signed
`rank rest). Repeat measurements of the same vertebral levels
`after a 2-week interval with the same observer demonstrated an
`error of::': 1.1 mm.
`
`Assessment of Cement Leakage Cement leakage was re(cid:173)
`corded prospectively at surgery. Postoperative radiograpbs
`
`were also examined for the presence of leakage of cement.
`Cement leakage was recorded on the basis of position and
`correlated with any postoperative clinical symptoms.
`
`Measurement of Early Outcome; Clinical Assessment
`Outcome data were obtained by comparing preoperative and
`latest postoperative SF-36 data. Patients completed the SF36
`questionnaire without assistance if feasible at the time. of their
`preoperative assessment and at subsequent 1-, 6-, and 12"week
`follow-up appointments. The Wilcoxon signed rank test was
`used for statistical analysis of SF-36 data. A P value o( < 0.05
`was deemed significant.
`
`• Results
`All 30 patients tolerated the procedure well, and im(cid:173)
`provement in pain and mobility was seen early. Virtually
`all patients subjectively reported immediate relief of their
`typical fracture pain, and no patient complained of
`worse pain at the treated levels. The levels treated ranged
`from T6 to L5, the majority at the thoracolumbar junc(cid:173)
`tion (Tll = 8, Tl2 = 15, L1 = 12). The ratio of general
`to local anesthesia used was 6:1. Kyphoplasty was per(cid:173)
`formed via transpedicular and cxtrapedicular routes in
`40% and 60% of cases, respectively. After surgery all
`patients were admitted to the 23-bour stay unit. Twenty
`patients were discharged home the following morning,
`seven were discharged that same afternoon, five re(cid:173)
`mained 2 days, four remained 3 days, one remained 16
`days, and one patient remained as a long stay inpatient
`because of premorbid conditions.
`In all cases a cavity was successfully created in the
`vertebral body. The average cavity/IBT volume was 2.6
`mL (range 0.5-5.0 mL). The average lBT inflation pres-
`
`STRYKER EXHIBIT 1030, pg. 3
`
`

`
`1634 Spine o Volume 26 o Number 14 o 2001
`
`Post height = 3 7mm
`Mid height= 20mm
`Kyphosis = 16 deg
`
`Post height = 3 7mm
`Mid height= 12mm
`Kyphosis = 25 deg
`
`Post height = 3 7mm
`Mid height= 28mm
`Kyphosis = 10 deg
`
`operative lateral radiographs, measurement of vertebral
`height was difficult in that the endplates could not rea(cid:173)
`sonably be defined. In these cases an estimate was used,
`or if this were not possible, no value was obtained for
`that level. At four levels we had complete restoration,
`and in 15 there was no appreciable height restoration.
`SF-36 scores for Bodily Pain, Physical Function, Role
`Physical, Vitality, and Mental Health all showed im(cid:173)
`provement (Table 1 and Figure 5). Bodily Pain scores
`
`Figure 3. Example of height restoration and measurement.
`
`sure was 130 psi (range 70-250 psi). In 14 cases the IBT
`ruptured during the procedure. All but one of the rup(cid:173)
`tures was a pinhole in the balloon component, reflecting
`puncture by sharp pieces of bone. Most of the failures
`occurred after maximum inflation was achieved and a
`replacement IBT was not required. In three cases the IBT
`failed earlier in the procedure and a replacement was
`required. In all instances the ruptured tamp was easily
`withdrawn. Balloon inflation asymmetry was noted dur(cid:173)
`ing the early stages of inflation in some cases. In most
`instances further inflation resulted in a more symmetric
`pa ttem. It was thought that this was a consequence ofthe
`IBT meeting bone of different densities.
`Radiologic height measurement of all 70 levels treated
`demonstrated that the mean central vertebral height lost
`was 8.7 mm (range 2-17 mm). The mean percentage of
`height lost that was restored by the procedure was 35%
`(range 0-100%). Examination of the data graphically,
`however, showed a non-Gaussian distribution with rwo
`subsets of patients (Figure 4 ). The vertebral levels treated
`can be divided into those in which some height was re(cid:173)
`stored (70%) and those in which no height was restored
`(30%). When the group in which height was restored is
`examined separately the mean height restored is 46.8%.
`The distribution of this group is uniform (not bimodal);
`therefore, the term mean here has greater validity. The
`absolute mean height gain for the latter group is 4.1 mm
`(P = 0.001) compared with 2.9 mm (P = 0.001) when all
`levels treated are considered.
`In some instances because of the osteopenic nature of
`the bone or the quality of either the preoperative or post-
`
`Levels
`.
`16
`
`14
`
`12
`
`10
`
`8
`
`6
`
`4
`
`2
`
`0
`
`0 ·
`l 0%
`
`11-
`200/9
`
`1', n
`
`61·
`Sl·
`41·
`31·
`21·
`700/o
`60%
`50%
`40%
`30%
`Percentage height restored
`
`71·
`RO%
`
`81·
`90%
`
`91·
`1 OO'h
`
`Figure 4. Percentage height restoration, single midline measure,
`average duration of symptoms = 5.9 months.
`
`STRYKER EXHIBIT 1030, pg. 4
`
`

`
`Kyphopl3sly and Vertebral Compression Fractures • Lieberman et at 1635
`
`Table I. Patient Information, Height Measurements, and SF-36 Data
`
`Duration of
`Prefracrur• %Height
`St;'ptomst Follow-Up Levels
`Post Rx
`Pre Rx
`onths Months Treated HeighVmm HeighVmm HelghtJmm Restored
`
`Patlant
`
`SF-36 Pratreatment
`
`SF-36 Post-treatment
`
`rost-Ojllll'etlve
`Hosga~l StavfOnf
`(0.> = Oaytasa
`
`2
`
`3
`
`G
`
`1
`B
`
`g
`
`10
`11
`12
`
`13
`
`0,8
`2.2
`
`2
`
`12
`
`11.5
`
`6.7
`
`15
`
`7
`
`13.6
`
`2
`24
`
`2
`
`4
`1
`18
`
`10.5
`10
`
`12.4
`
`2.5
`2
`8.7
`
`10
`
`10
`
`16
`17
`20
`15
`17
`15
`Z2
`24
`15
`11
`17
`15
`17
`
`9
`15
`16
`11
`15
`12
`17
`
`20
`23
`
`17
`17
`21
`13
`20
`
`19
`21
`20
`11
`17
`23
`28
`28
`15
`11
`20
`20
`21
`
`17
`20
`16
`16
`17
`18
`17
`
`20
`27
`
`17
`17
`22
`15
`20
`
`15
`15
`16
`
`24
`24
`22
`25
`2S
`25
`2S
`2S
`18
`18
`25
`25
`25
`
`Z2
`22
`22
`20
`20
`20
`20
`
`30
`30
`
`22
`25
`25
`25
`30
`
`zg
`33
`30
`
`0'11*0*75"20*1 2.s•-"92
`
`70"0*1 OO*n*50"8B*-"92
`
`0'11*12*35'35*12.5*100*1111 70'11*74*47*66*75*50"110
`
`38% 35*25*32"67*15*75*100"72 25"0*74*57~4D*SS•&7"76
`57%
`0
`20%
`0
`80
`100
`100
`0
`D
`37.5
`50
`50
`
`20*8*1 0*82*30"0*1 00*72
`
`85*75*41 *82*65*88*1 00'92
`
`0"0"0"-*35'60*100*72
`
`50*0*4 1 *77*50•62.5*1 00*1111
`
`0.5
`1
`1
`1
`
`B
`
`1
`3
`
`0.5
`
`62
`71
`0
`56
`40
`76
`0
`
`0
`57
`
`0
`0
`25
`17
`D
`
`26
`0
`18
`
`0'11*0*67"11*0*0•36
`
`1 5*0*22*40*40"37 .5*0*40
`
`5* 0"0"92*5"25*1 00*56
`0*0'0*55*80*0*1 00*84
`
`95*1 00*84*n"35*50'1J•ez
`0*0*42*57"90*12.5'100*76
`
`5"0*22*20"35*25*100*60
`
`0"11*22*55*5*50'11*56
`
`5'1J*22"3fi*35*50'1J*B0
`
`80"25*74*27*65*100*100*96
`
`3
`long stay
`1
`
`25*0*42*42*20*100*0*52
`
`50"11*84*65*25*62.5"100*92
`
`0-5
`
`80"0*22*50'80"75*100*80 80*100*100'62*50'100'100*60
`
`TS
`L1
`L2
`TB
`no
`112
`T9
`112
`L1
`T11
`T12
`T11
`112
`L1
`L2
`L3
`T11
`112
`L1
`n
`T10
`T11
`T12
`L4
`L6
`L1
`l1
`n
`T9
`T11
`T12
`L1
`L4
`L5
`T12
`L6
`112
`T12
`1.3
`L5
`T12
`L1
`112
`L3
`L3
`T6
`T9
`Tll
`L1
`LS
`TS
`T8
`TS
`T11
`T12
`L2
`T12
`L1
`L2
`T9
`T12
`T11
`L1
`L2
`n
`T6
`T8
`L3
`L1
`L3
`
`10
`15
`13
`
`17
`
`16
`6
`16
`
`10
`20
`
`20
`15
`22
`
`25
`28
`285
`
`21
`25
`28
`7
`
`19
`15
`23
`
`14
`15
`
`16
`
`17
`18
`19
`20
`
`21
`
`22
`23
`
`24
`
`25
`
`26
`
`27
`28
`
`28
`30
`
`0.5
`0.5
`
`24
`24
`4
`6
`
`0.8
`3
`
`1.5
`
`3
`
`8
`1
`
`1
`6
`
`1.3
`
`2.0
`7.1
`
`9
`
`8.3
`5.3
`
`7.0
`
`0.8
`
`0.8
`6.4
`
`6.0
`6.0
`
`19
`
`18
`9
`21
`
`22
`20
`
`20
`20.4
`21.6
`
`26.4
`3D
`3D
`
`23.4
`311.8
`30.B
`7
`
`21i
`20
`25.3
`
`25
`
`22
`22
`23
`
`28
`30
`
`Z6
`27
`27
`
`3D
`30
`30
`
`28
`33
`33
`20
`
`36
`27
`33
`
`25
`
`33
`19
`71
`
`67
`0
`
`0
`45
`0
`
`2S
`100
`100
`
`34
`73
`56
`0
`
`35
`42
`23
`
`15'11*12°40*0*0*0*44
`
`60*0*52'62'25'50*0*76
`
`0"0"0*72*0'12.5*67*40
`
`90*100*74"87*80*100*100*68
`
`50*100*100*65*50*100*100*84
`5*0*22"45*20*38*0*28
`20*11"12*20*35*25*1 00"110 70*25*52'1 0*50*75"1 00'66
`
`5"0"0*40*35*83*100"64
`
`55*0'41"117"35*62.5'11*52
`
`5*0*12*50"20*13"0*60
`
`5'11*31"115"00*87 .5*100*92
`
`15"11*12*82'30*25*1 00*52 15*0*0*82*45"25"0*80
`0*0"0*97"0"0*100*80
`15*0*62*67*60*50*100*96
`
`5"0"12*20*10*0*100*40
`
`45*100"62*60"35*87.5.100'84
`
`2
`3
`
`16
`
`2
`o.s
`0,5
`u.s
`
`2.0
`
`0.6
`1
`2
`1
`1
`
`• SF-36 Scores ere separated by an asterisk. The aight scores ere physical function, role function, bodily pain, gene<al health, vitality, social functioning, role
`emotional, mental health.
`
`STRYKER EXHIBIT 1030, pg. 5
`
`

`
`1636 Spine • Volume 26 • Number 14 • 2001
`
`80
`70
`
`50
`
`40
`
`30
`
`~~~ /
`
`~
`
`Cpre
`•post
`
`+ Age mulch norm
`
`60 ~ -.:
`!0 ~ _0 J ,!J
`10 D
`
`0
`
`PF Rl' BP GH v
`Figure 5. SF-36 outcome scores, pre- and post-treatment.
`
`SF RE MH
`
`improved from 11.6 to 58.7 (P = 0.0001). Physical
`Function improved from 11.7 to47.4 (P = 0.0020). Role
`Physical improved from 1.2 to 29.8 (P = 0.57). Vitality
`scores improved from 24.8 to 47.9 (P = 0.0013). Mental
`Health improved from 59.2 to 71.1 (P = 0.015). Social
`Functioning improved from 28.6 co 69.0 (P = 0.0004).
`General Health and Role Emotional scores did not show
`significant improvement.
`Cement extravasation was seen at six levels (8.6%).
`Cement entered the epidt1ra l space in one patient, the
`disc space on two occasions, :md t.he paraspinal tissues in
`three cases. As soon as tbis was seen on the fluoroscope,
`cement injection was stopped. No problems were identi(cid:173)
`fied clinicallv as a result of these extravasations immedi(cid:173)
`ately after st;rgery or at final follow-up. In the one case of
`cement in the epidural space (T12Ievel), the cement lay(cid:173)
`ered around the base of the pedicle. At the time it was
`thought that cement was injected prematurely allowing it
`to flow out a small venous sinus. In the remaining cases
`cement appeared to leak through the superior endplate
`or a sidewall crack.
`At final follow-up (mean= 6. 7 months) there were no
`major complications related directly to the use of this
`technique or the IBT. There were no injuries to spinal or
`extraspinal tissues as a result of guide pin, obturator, or
`cannula placement. Bone tamp expansion was bounded
`by the vertebral body, and a cavity was created success(cid:173)
`fully in all cases. One patient developed perioperative
`pulmonary edema and a myocardial infarction second(cid:173)
`ary to intraoperative fluid overload. Rib fractures oc(cid:173)
`curred in two patients related to positioning.
`
`• Discussion
`
`The results of this initial series of patients show that
`kyphoplasty is a well-tolerated procedure indicated for
`the treatment of painful VCFs. Kyphoplasry is associated
`with early clinical improvement of pain and function as
`well as restoration of vertebral body height.
`We anticipate much debate in the near future in dif(cid:173)
`ferentiating the kyphoplasty from the vertcbroplasty
`technique. On the basis of pain relief, this will be difficult
`as excellent pain relief is seen with both techniques.
`However, our findings support the differentiation of the
`two techniques on the basis of height restoration and risk
`
`of cement extravasation. Our findings of low rates of
`cement extravasation in kyphoplasty, compared with
`published vertebroplasty series, stlpport the hypothesis
`that injection of high-viscosity cement into a previously
`formed cavity is a significant improvcmen~ over the in(cid:173)
`jection of low-viscosity liquid cement into the unreduced
`vertebral body, on the grounds of safety alone. Restora(cid:173)
`tion of height and sagittal aUgrunenrwill work to protect
`vulnerable vertebral levels a bove or be low by minimizing
`force transfer. Kyphoplasry may have an advantage in
`this regard, but its true benefit will only be borne our in a
`longer-term study of subsequent fractures.
`The method we used to detect height restoration ex(cid:173)
`amines central vertical height restoration on lateral plain
`radiographs. Although height restoration was seen, this
`is a crude method of assessment. It does not measure the
`actual deformity as a whole. For our ongoing study we
`now use preoperative and postoperative 3-foot standing
`lateral radiographs to measure the kyphosis and the ver(cid:173)
`tebral body height. We are also devising alternate imag(cid:173)
`ing methods to measure restoration of vertebral body
`volume in addition to height. In this study we made no
`attempt to stratify or account for age of fracmre because
`all comers were included in this efficacy study. We believe
`this has skewed the height restoration results. In the en(cid:173)
`tire group we saw a 35% restoration of vertebral height,
`but longer follow-up is required to see if this will be
`maintained. A number of the levels treated were more
`chronic, and in some we were able to restore height and
`in others we were not. However, despite the chronic na(cid:173)
`ture of some fractures, we were able to produce a cavity
`in all vertebrae treated, and in this initial experience we
`got the impression that we were more predictably able
`to restore height in those fractures less than 3 months
`of age.
`This Phase I efficacy study suggests that kyphoplasty is
`a safe procedure. The IBT functioned well and restored
`vertebral height. Clinical improvement often occurred in
`the first 24 hours after surgery. In some, successful ky(cid:173)
`phoplasty enabled the elderly patient to mobilize, having
`previously been unable to so. It is po&sible tbar in the
`future kyphoplasty may be shown to be worthwhile im(cid:173)
`mediately after vertebral fracture in some high-risk pa(cid:173)
`tients to enable early mobilization and decrease mortal(cid:173)
`ity. In distal radius fractures or hip fracture we are
`reluctant to accept biomechanically compromised align(cid:173)
`ment. In the spine we no longer have to accept a biome(cid:173)
`chanically or physiologically compromised situation be(cid:173)
`cause we now have a method of early reduction and
`stabilization for patients with osteoporotic compression
`fractures. Considering the increased mortality associated
`with osteoporotic compression fractures, early mobiliza(cid:173)
`tion in these patients is of prime importance, synony(cid:173)
`mous with the elderly hip fracture population.
`There is also considerable interest in the use of a bio(cid:173)
`compatible bone cement substitute in the augmentation
`of osteoporotic compression fractures. 2 With the use of
`synthetic bone products we anticipate prophylactic inter-
`
`STRYKER EXHIBIT 1030, pg. 6
`
`

`
`diagnosed \'e:rtrbr3l fractures: a population-based study in Rochester, Min(cid:173)
`ntsota, 19H.5-1989. 1 Uone Miner Res 1992;7:221-7.
`6. Corter B, Cotton A, Boutr~· N, et al. Percutaneous vertehroplasty in the
`t1eatme11t of osteoporotic vertebrc\l compression fr11ctures: an open pros pee·
`tivc study. 1 Rheumatol 1999;2.6:2222-8.
`7. Deramond H, Deprit'ster C, Galibert P) Le Gar~ D. l)crcutaneous verlebro·
`plasty with polymcthylmethac.rylate: technique, indications and result•. Ra·
`diol Clin North Am 1998;36:533-46.
`8. Galibcrt P. Derarnond H. Nor~ prilirninaire sur le traircment des angiomc.s
`"Yerttbraux par vcrr€broplr.srie acr)'liquc percutanCc. Neurochirurgie 1987;
`33:166-7.
`9. Greendale GA, llarrett-Connor E, Ingles S, HaileR. !.•t< physical and func·
`tiona! effects of osteoporotic fra.cturr.s in women: the Rancho Bernardo
`Study . .J Am Geriotr Soc 1995;43:955-61.
`I 0. Heanq• RP, The natural history of vercebral osreoporosi.o;;: is low bone mass
`an epiphenomenon? Bone 1992; 13(suppl 2):2.>-6.
`1 I. Jensen ME, Evans A], Mathis JM, Ka!lrnes DF, Cloft Hj, Dion JE, Percuta(cid:173)
`neous polymethy!mcthacrylate vertebropbsty in the treatment of oste:opo(cid:173)
`rotic vertebral body c.:ompresslon fractures: tc:c:hnical aipcct(O. A•n] Nt"uro(cid:173)
`radioi1997;1S:1897-904.
`12. Kado D?vf, Browner WS. Palermo L, Nevitt !v1C, Ccna.nt HK, Cummings1
`SR. Vcrrebral fractures and mortality in older women: a prospective study.
`Arch Intern Med 1999;159:1215-20.
`1.1. I.eech1A, Dulberg C, Keliie S, Pattie L, Gay j. Relationship of lung function
`to severity of osteoporosis in women. Am Rev Respir Dis 1990;141:68-71.
`14. Lyles KW, Gold DT, Shipp KM, l'iepcr CF, Martine>. S, Mulhauscn, PL.
`Association of osteoporotic \'Cttebra ! fracnaes with impaired functional sta(cid:173)
`tus. 1\m J Med 1993;94:595-601.
`15. M3this jJv1, Petri M, Naff N. Percutaneous verrebroplasty uecwnent of ste(cid:173)
`roid-induced osteoporotic compression fractures .A rthdtis Rheum 1998;41:
`171-.S.
`Jr;. Melton LJ Ill. Epidemiology ui spinal osteoporosis. Spine J997;22jsuppl):
`2-11.
`17. Ri~~' BL, Melton LJ Ill. ln,•oludonal osteoporosis. N Engi.J Med !9H6;314:
`"1676-86.
`18. Silverman SL. Tl)e clinical consequences of vertebr:d compression fraclurr;:.
`Bone l992;13(suppl 2),17-3 i.
`19. Weill A, Chiras J, Sirnon JM, Rose M, Sola·Martin<z T, Enkaoua E. Spinal
`merastascs: indications for and results of percur:me01.1S injection of acrylic
`ccmenr. Radiology 1996;199:241-7.
`
`Address reprint requests to
`
`I.H. Lieberman, MD
`Minimally Invasive Surgery Cente~·
`9500 Euclid Ave., Desk .4.-41
`Cl1•velalld, OH 44195
`E-mail: lieberi@ccf.org
`
`Kyphoplasty and Vertebral Compression Fractures • Liehcmtan ct al 1637
`----
`vention to prevent painful collapse. Until the efficacy of
`these substances is tested in the spine, one of the major
`questions in this procedure as it is now performed is as
`follows: "What is the natural history of cement in the
`osteoporotic vertebral body over 20-30 years?"
`The long-term benefits of kyphoplasty arc currently
`being studied in a multicenter Phase II randomized con(cid:173)
`trolled trial.
`
`Acknowledgment
`
`The authors thank Kyphon Inc. (Sunnyvale, CA) for pro(cid:173)
`viding the equipment and technical support for this
`study.
`
`• Key Points
`
`• Kyphoplasty using the inflatable bone tamp is a
`safe and effective technique to reduce and stabilize
`osteoporotic vertebral compression fractures
`• The inflatable bone tamp was able to restore lost
`vertebral height and create a cavity for cement fill.
`• The cement fill can be performed under low pres(cid:173)
`sure with viscous cement, thus minimizing the risk
`of cement leakage.
`
`• Kyphop\asty was associated with a statistically
`significant improvement in pain and function as
`measured with SF-36 in patients with vertebral
`compression fractures.
`
`References
`
`1. Barr JD, Barr MS, Lemley TJ, McCann RM. l'ercutaneous 1•ertebroplasty for
`pain relief and spinal stabilisation. Spine 2000;25:923-S.
`2. Bo!ltrum MPG, Lane ]l\1 . Puture Jircctions: augment3tion of osteoporotic
`vertebral bodies. Spine 1997;2.2(suppl):38-42.
`J. Cook DJ, Guyatt GH, Adachi JD, et al. Quality of life im1es in women with
`vertebral fractures due ro osteoporosis. Arthriris Rheum 1993;36:7.50-6.
`4. Cooper C, Atkinson Ej,Jacobsen Sj, et al. Population-based study of survival
`after osteoporotic fra•tures. Arn .J Epidemiol199.3;137:100!-5.
`5. Cooper C, Atkinson EJ, O'Fallon WM, Melton LJ HI. Incidence of clinical!y
`
`Point of View
`
`Nancy Birkmeyer. PhD
`Department of Surgery
`Dartmouth Medical School
`Hanover, New Hampshire
`
`The techniques of percutaneous vertebroplasty and ky(cid:173)
`phoplasty for treating osteoporotic compression frac(cid:173)
`tures are rapidly disseminating throughout the United
`States and Europe. These new treatments for osteopo(cid:173)
`rotic vertebral fractures involve augmentation of the af(cid:173)
`fected vertebral bodies with acrylic bone cement. Inky(cid:173)
`phoplasty an inflatable bone tamp is used in an effort to
`
`restore vertebral height and create a cavity for the inser(cid:173)
`tion of cement. Kyphoplasty therefore offers the possible
`advantages over vertebroplasty of reducing spinal defor(cid:173)
`mity and risks of cement leakage.
`Despite increasing use, little is known about the effec(cid:173)
`tiveness of these

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket